BRIEF published on 06/18/2024 at 07:05, 5 months 3 days ago EUROAPI and Priothera Enter CDMO Collaboration to Advance Oncology Project CDMO Oncology EUROAPI Priothera Mocravimod
PRESS RELEASE published on 06/18/2024 at 07:00, 5 months 3 days ago EUROAPI and Priothera enter into CDMO collaboration to advance oncology project EUROAPI and Priothera have entered a 5-year CDMO collaboration to advance an innovative oncology molecule for blood cancers, aiming to improve CAR-T cell therapies EUROAPI Priothera Mocravimod CDMO Collaboration Oncology Project
BRIEF published on 06/06/2024 at 17:58, 5 months 14 days ago EUROAPI Accelerates Financing Discussions for FOCUS-27 Project Financing Strategic Transformation EUROAPI FOCUS-27
BRIEF published on 06/06/2024 at 17:58, 5 months 14 days ago EUROAPI accélère les discussions de financement pour le projet FOCUS-27 Financement Transformation Stratégique EUROAPI FOCUS-27
PRESS RELEASE published on 06/06/2024 at 17:53, 5 months 14 days ago Information marché Financement du projet de transformation FOCUS-27 EUROAPI a mandaté un tiers pour le financement de son projet stratégique FOCUS-27. Des progrès importants ont été réalisés. Découvrez les détails de cette démarche Financement EUROAPI FOCUS-27 Mandataire Ad Hoc Projet De Transformation
PRESS RELEASE published on 06/06/2024 at 17:53, 5 months 14 days ago Market update : FOCUS-27 transformation project financing EUROAPI appoints mandataire ad hoc for FOCUS-27 project financing discussions, making substantial progress. Learn more about EUROAPI and its active ingredient solutions Project Financing EUROAPI FOCUS-27 Mandataire Ad Hoc Active Ingredient Solutions
BRIEF published on 06/06/2024 at 07:05, 5 months 15 days ago EUROAPI franchit une étape majeure de l'IPCEI en matière de santé avec une notification officielle de la Commission européenne Industrie Pharmaceutique EUROAPI Commission Européenne IPCEI Financement Publique
BRIEF published on 06/06/2024 at 07:05, 5 months 15 days ago EUROAPI Reaches Major Health IPCEI Milestone with Official Notification from European Commission Pharmaceutical Industry European Commission EUROAPI IPCEI Public Funding
PRESS RELEASE published on 06/06/2024 at 07:00, 5 months 15 days ago EUROAPI reaches major Health IPCEI milestone with official notification from European Commission EUROAPI selected for EUR 1 billion IPCEI funding by European Commission to enhance pharmaceutical sector competitiveness and sustainability European Commission R&D EUROAPI IPCEI Pharmaceutical Sector
BRIEF published on 05/23/2024 at 07:05, 5 months 29 days ago EUROAPI remporte un contrat de fourniture de 130 à 150 millions d'euros dans le secteur de la santé animale La Santé Des Animaux EUROAPI Contrat De Fourniture Produits Vétérinaires Projet FOCUS-27
Published on 11/21/2024 at 12:00, 45 minutes ago Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 45 minutes ago Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 15 minutes ago FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 2 hours 42 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 2 hours 45 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 12:35, 10 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 30 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 11:30, 1 hour 15 minutes ago APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 06:58, 5 hours 47 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 47 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 47 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 16 hours 38 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 25 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
